PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fighting fungal foes: Walnut's genetic armor against anthracnose revealed

Fighting fungal foes: Walnut's genetic armor against anthracnose revealed
2024-08-28
(Press-News.org) A pivotal study has pinpointed a gene module crucial for enhancing walnut trees' resistance to anthracnose, a widespread fungal disease threatening the walnut industry. The research reveals how the JrPHL8-JrWRKY4-JrSTH2L module regulates disease defense, opening up new opportunities for breeding resistant walnut varieties and promoting sustainable cultivation practices.

Anthracnose, caused by Colletotrichum gloeosporioides, poses a significant threat to walnut production, causing severe losses in yield and quality. Traditional control methods are limited, and environmental concerns drive the need for alternative strategies. Transcription factors like WRKYs and MYBs are key in plant immunity, yet the molecular mechanisms behind walnut resistance to anthracnose have remained largely unexplored. Given these challenges, an in-depth study of the molecular pathways in walnut defense is essential.

Published (DOI: 10.1093/hr/uhae148) in Horticulture Research on May 28, 2024, researchers from Shandong Agricultural University unveiled the role of the JrPHL8-JrWRKY4-JrSTH2L module in walnut resistance to anthracnose. This study marks a significant leap in understanding how transcription factors and interacting proteins contribute to disease resistance in walnuts, offering new directions for developing disease-resistant varieties.

The study identifies JrWRKY4 as a key transcription factor enhancing walnut resistance to anthracnose. Positioned in the nucleus, JrWRKY4 functions as a transcriptional activator, binding to the W-box in the JrSTH2L gene promoter, thereby boosting its expression—a crucial step in the plant's immune response. The research also reveals that JrVQ4 protein interaction inhibits JrWRKY4’s activation of JrSTH2L, suggesting a complex regulatory system. Additionally, the MYB transcription factor JrPHL8 was found to bind to the MBS element in the JrWRKY4 promoter, enhancing its transcription and further strengthening the plant’s resistance. Together, these findings provide a detailed understanding of the JrPHL8-JrWRKY4-JrSTH2L module’s role in anthracnose defense, highlighting its potential as a target for breeding disease-resistant walnut varieties.

Dr. Hongcheng Fang, the lead researcher, highlighted the significance of these findings, stating, “This discovery not only elucidates the complex regulatory network behind walnut resistance to anthracnose but also opens up new avenues for developing disease-resistant cultivars. By focusing on the JrPHL8-JrWRKY4-JrSTH2L module, we can enhance walnuts' natural defense mechanisms, reducing dependency on chemical treatments and fostering more sustainable agricultural practices.”

The insights gained from this research extend beyond fundamental science. The JrPHL8-JrWRKY4-JrSTH2L module presents a promising target for genetic engineering and breeding programs aimed at producing anthracnose-resistant walnuts. This approach aligns with global efforts to minimize pesticide use in agriculture and could be applied to other crops facing similar pathogen challenges, broadening the potential impact on crop protection and food security.

###

References

DOI

10.1093/hr/uhae148

Original Source URL

https://doi.org/10.1093/hr/uhae148

Funding information

This work is supported by the National Natural Science Foundation of China (32371919), the Improved Variety Program of Shandong Province of China (2020LZGC090102), and the Natural Science Foundation of Shandong Province (ZR2022QC031).

About Horticulture Research

Horticulture Research is an open access journal of Nanjing Agricultural University and ranked number two in the Horticulture category of the Journal Citation Reports ™ from Clarivate, 2023. The journal is committed to publishing original research articles, reviews, perspectives, comments, correspondence articles and letters to the editor related to all major horticultural plants and disciplines, including biotechnology, breeding, cellular and molecular biology, evolution, genetics, inter-species interactions, physiology, and the origination and domestication of crops.

END

[Attachments] See images for this press release:
Fighting fungal foes: Walnut's genetic armor against anthracnose revealed Fighting fungal foes: Walnut's genetic armor against anthracnose revealed 2 Fighting fungal foes: Walnut's genetic armor against anthracnose revealed 3

ELSE PRESS RELEASES FROM THIS DATE:

Rice engineers develop AI system for real-time sensing of flooded roads

Rice engineers develop AI system for real-time sensing of flooded roads
2024-08-28
Roadway-related incidents are a leading cause of flood fatalities nationwide, but limited flood-reporting tools make it difficult to evaluate road conditions in real time. Existing tools — traffic cameras, water-level sensors and even social media data — can provide observations of flooding, but they are often not primarily designed for sensing flood conditions on roads and do not work in conjunction. A network of sensors could improve situational flood level awareness; however, they are expensive to operate at scale. Engineers at Rice University have developed a possible solution to this problem: an automated data ...

Dr. David A. Schwartz receives 39th annual Alton Ochsner Award

Dr. David A. Schwartz receives 39th annual Alton Ochsner Award
2024-08-28
NEW ORLEANS – Ochsner Health has announced David A. Schwartz, MD, as the 2024 winner of the Alton Ochsner Award Relating Smoking and Disease. Dr. Schwartz is a Distinguished Professor of Medicine and Immunology and director of the Program to Advance Physician Scientists and Translational Research at University of Colorado’s Anschutz School of Medicine.  Dr. Schwartz won the 39th annual Alton Ochsner Award for his research on how genetic and environmental factors, including smoking, contribute to idiopathic pulmonary fibrosis (IPF). He found that ...

New data: Solar at K-12 schools quadrupled nationwide during the last ten years

New data: Solar at K-12 schools quadrupled nationwide during the last ten years
2024-08-28
Charlottesville, VA — Schools across the country are rapidly switching to solar power to meet their energy needs while gaining significant cost-savings, boosting climate resilience, and supporting workforce development, according to a new report from clean energy nonprofit Generation180. Since the start of 2014, the amount of solar capacity installed at K-12 schools has more than quadrupled nationwide. According to Brighter Future: A Study of Solar on K-12 Schools, 5th edition, over 6.2 million U.S. K-12 students– or more than one in nine students – now attend a school that utilizes solar power. In 2022-2023, over 800 schools added solar arrays, which is enough ...

Thermochromic material could make indoor temperature control more energy-efficient

Thermochromic material could make indoor temperature control more energy-efficient
2024-08-28
HOUSTON – (Aug. 28, 2024) – Rice University researchers have developed a smart material that adjusts its transparency with changes in temperature, outperforming similar materials in terms of durability, transparency and responsiveness. The new polymer blend could significantly enhance energy efficiency for indoor space cooling, according to a new study published in Joule. Cooling off can be a matter of life or death, but air conditioning ⎯ when and if available ⎯ already accounts for 7% of the world’s energy use and 3% of carbon emissions. With temperatures hitting record ...

Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists

2024-08-28
The Damon Runyon Cancer Research Foundation has named 16 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. This prestigious Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total) to investigate cancer causes, mechanisms, therapies, and prevention. “What is so exciting—and so challenging—about being a postdoc is that you’re called to take what you know and apply ...

Primary care providers urged to assist patients who engage in emotional eating

2024-08-28
August 28, 2024 — Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts. According to their article published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer, emotional eating is associated with myriad health problems, including the experience of ...

Half of Uber, Lyft trips replace more sustainable options

Half of Uber, Lyft trips replace more sustainable options
2024-08-28
More than 50% of ride-hailing trips taken by surveyed riders in California replaced more sustainable forms of transportation — such as walking, cycling, carpooling, and public transit — or created new vehicle miles, according to a study from the University of California, Davis Institute of Transportation Studies.  The study was conducted to help guide development of the Clean Miles Standard, a state regulation designed by the California Air Resources Board to reduce the greenhouse gas emissions from ride-hailing services.  Published in Transportation Research ...

miR-10b Inhibition: A strategy for treating metastatic breast cancer

miR-10b Inhibition: A strategy for treating metastatic breast cancer
2024-08-28
“We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” BUFFALO, NY- August 28, 2024 – A new research paper was published in Oncotarget's Volume 15 on August 26, 2024, entitled, “Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties.” As stated within the Abstract of the paper, despite advances in breast cancer screening and treatment, the prognosis for metastatic disease remains dismal, with ...

Love is blind for male fruit flies who will choose sex over safety

Love is blind for male fruit flies who will choose sex over safety
2024-08-28
Male fruit flies will become oblivious to physical danger as they become more engaged in courtship and sex, new research shows. Researchers at the University of Birmingham have shown that pursuit of a coveted reward – in this case a female fly – will cause a male fruit fly to ignore threats such as predation. In the study, published today (28 Aug) in Nature, the team was able to show for the first time the neural networks in the fly’s brain that direct this decision-making process, revealing the neurotransmitter dopamine has a leading role to play. Lead researcher Dr Carolina Rezaval said: “Every day we make decisions that require us to ...

Kidney donors’ risk of death at all-time low

2024-08-28
The risk of death for people who donate a kidney for transplantation — already small a decade ago — has dropped by more than half since then, a new study shows. Each year, roughly 6,000 Americans volunteer to donate a kidney, according to the Organ Procurement and Transplantation Network. Before undergoing the procedure, donors are informed of the potential risks, including death. Based on data from 1995 through 2009, experts had originally predicted that about three of every 10,000 donors were likely to die within three months of the procedure. The authors of the ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Fighting fungal foes: Walnut's genetic armor against anthracnose revealed